Purchase Order 75F40123P00073
Award Date
3/29/23
Potential Completion Date
9/1/23
Potential Value
$19K
Federal Agency
Food and Drug Administration
Awardee
Arraystar Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $16,514 purchase order to Arraystar Inc. to provide exosome miRNA profiling and sequencing services. The firm fixed price contract has a period of performance from September 19, 2023 through April 25, 2024 and will be performed in Silver Spring, Maryland. Arraystar will deliver the requested exosome profiling and sequencing services to support HHS FDA programs. No subcontractors or set aside designations...
The Department of Health and Human Services Food and Drug Administration awarded a $21,480 firm fixed price purchase order to Arraystar Inc. to provide transfer RNA sequencing services. The contract has a period of performance from August 1, 2023 through July 31, 2024 and will be performed in Potomac, Maryland. No additional context was provided regarding the FDA's programs or use of the contracted sequencing services. The award was made directly to Arraystar Inc. as the prime contractor, with...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to LC Sciences, a minority-owned, woman-owned, and Asian-Pacific American-owned business that manufactures goods and provides services for genomics and proteomics research. The $20,805 contract is for the delivery of "Mouse MicroRNA Microarray" services, which includes library preparation, sequencing of various types of RNA samples, and sequencing analysis. The contract has no set-aside...
This federal contract award to Nanostring Technologies, Inc. is for the provision of the NANOSTRING HUMAN MIRNA ASSAY KIT, valued at $10,789.01. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is a firm fixed-price purchase order with a completion date of September 29, 2015. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms...
The Department of Health and Human Services Food and Drug Administration awarded a $136,975.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for MiSeq sequencing service agreements covering four instruments, with a performance period ending on March 8, 2023. Illumina has previously received prime federal awards from agencies like the National Institutes of Health and Department of Veterans...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Bioarray Solutions LTD, a for-profit manufacturer, to provide bioarray reagents. The contract has a ceiling value of $40,660.58 and a period of performance ending on January 31, 2019. This award is not set aside and is one of multiple prime contracts that Bioarray Solutions has received from the NIH Clinical Center in recent years to provide a range of products and services in...
This is a $36,000.00 firm fixed-price purchase order awarded by the U.S. Department of Agriculture (USDA) Agricultural Research Service (ARS) to Mirxes Pte. LTD., a for-profit organization, for a service called "STEREO-SEQ SERVICE". The award is for providing a spatial transcriptomics capability to measure gene activity in tissue samples with 500-nanometer resolution, which supports the ARS's Animal Genomics and Improvement Laboratory (AGIL) mission of accelerating genetic...
<p>This is a federal contract award from the Food and Drug Administration (FDA) to Girihlet Inc., a minority-owned, woman-owned small business, for sequencing services related to circular RNA. The contract has a ceiling value of $145,000.00 and is a firm fixed-price purchase order. The contract was awarded on September 16, 2015, with an ultimate completion date of October 9, 2016. The contract is set aside for small businesses.</p>
The Department of Health and Human Services Food and Drug Administration awarded a $56,042.50 firm fixed price purchase order to Firalis Molecular Precision SA for MIRNA whole transcriptome assay services in human plasma samples. Firalis, doing business as Firalis and a subsidiary of Firalis, will perform the requested microRNA whole transcriptome assays in human plasma samples to support FDA programs from July 2024 through November 2024. No major subcontractors or set aside designations were...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Agilent Technologies, Inc., a leading provider of analytical instruments, software, and consumables for laboratory use. The contract is for the delivery of Agilent's SUREPRINT G3 MIRNA RELEASE 21 MICROARRAY KIT, a specialized product for microarray analysis. The contract has a ceiling value of $24,998.40 and was awarded on August 18, 2015 with a completion date of September...